Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

NCT03173976 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Chondrosarcoma

Interventions

DRUG: Zoledronic Acid

Sponsor

Mohammed Milhem

Collaborators

[object Object]